0
0
0
A bill to amend the Federal Food, Drug, and Cosmetic Act to reauthorize the Critical Path Public-Private Partnerships.
12/29/2022, 4:33 PM
Congressional Summary of S 4152
This bill reauthorizes through FY2027 the Food and Drug Administration's Critical Path Public-Private Partnerships, which support medical product innovation, development, and safety.
Read the Full Bill
Current Status of Bill S 4152
Bill S 4152 is currently in the status of Bill Introduced since May 5, 2022. Bill S 4152 was introduced during Congress 117 and was introduced to the Senate on May 5, 2022. Bill S 4152's most recent activity was Read twice and referred to the Committee on Health, Education, Labor, and Pensions. as of May 5, 2022
Bipartisan Support of Bill S 4152
Total Number of Sponsors
1Democrat Sponsors
1Republican Sponsors
0Unaffiliated Sponsors
0Total Number of Cosponsors
2Democrat Cosponsors
1Republican Cosponsors
1Unaffiliated Cosponsors
0Policy Area and Potential Impact of Bill S 4152
Primary Policy Focus
HealthAlternate Title(s) of Bill S 4152
A bill to amend the Federal Food, Drug, and Cosmetic Act to reauthorize the Critical Path Public-Private Partnerships.
A bill to amend the Federal Food, Drug, and Cosmetic Act to reauthorize the Critical Path Public-Private Partnerships.
Comments
Sponsors and Cosponsors of S 4152
Latest Bills
Recover COVID Unemployment Fraud in Banks Act
Bill HR 8873May 30, 2026
No Aid for Ghost Students Act of 2026
Bill HR 7892May 30, 2026
Preventing Waste, Fraud, and Abuse in TANF Act
Bill HR 8872May 30, 2026
Student Aid Fraud Oversight and Accountability Act of 2026
Bill HR 7891May 30, 2026
Prove It Act
Bill HR 1163May 30, 2026
CONNECT Act
Bill HR 7995May 30, 2026
Foster Youth Workforce Opportunity Act
Bill HR 7343May 30, 2026
Foster Youth Postsecondary Education Access and Success Act
Bill HR 7463May 30, 2026
Fresh Starts for Foster Youth Act
Bill HR 7529May 30, 2026
Support for Expectant and Parenting Foster Youth Act
Bill HR 7655May 30, 2026
FDASLA Act of 2022
Bill S 4348December 29, 2022